secwatch / observer
8-K filed May 9, 2025, 7:59 PM ET ticker CNTN CIK 0001861657
leadership confidence high sentiment neutral materiality 0.50

Tharimmune appoints Vincent LoPriore as Executive Chairman, replacing Randy Milby

Canton Strategic Holdings, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Randy Milby

Chairman of the Board
CNTN · Canton Strategic Holdings, Inc.
Effective
2025-05-09
Successor
Vincent LoPriore
Filed
May 9, 2025, 7:59 PM ET
Mr. LoPriore shall replace Randy Milby who served as Chairman of the Board.
Appointed

Vincent LoPriore

Executive Chairman
CNTN · Canton Strategic Holdings, Inc.
Effective
2025-05-09
Filed
May 9, 2025, 7:59 PM ET
On May 9, 2025, the Board of Directors (the “Board”) of Tharimmune, Inc. (the “Company”) appointed Vincent LoPriore, a director of the Company, as Executive Chairman of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Randy Milby changed role as Chairman of the Board at Canton Strategic Holdings, Inc..

Action
stepped down
Role
Chairman of the Board
Exact text from the filing
Mr. LoPriore shall replace Randy Milby who served as Chairman of the Board.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Vincent LoPriore was appointed as Executive Chairman at Canton Strategic Holdings, Inc..

Action
appointed
Role
Executive Chairman
Exact text from the filing
On May 9, 2025, the Board of Directors (the “Board”) of Tharimmune, Inc. (the “Company”) appointed Vincent LoPriore, a director of the Company, as Executive Chairman of the Board, effective immediately.
View on SEC.gov

Canton Strategic Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001641172-25-009480
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.